US 12,434,281 B2
Single procedure indicators
Biswa P. Das, Tonawanda, NY (US); and Ashish Shah, East Amherst, NY (US)
Assigned to VIANT AS&O HOLDINGS, LLC, Foxborough, MA (US)
Filed by VIANT AS&O HOLDINGS, LLC, Foxborough, MA (US)
Filed on Mar. 22, 2021, as Appl. No. 17/208,638.
Application 17/208,638 is a continuation of application No. 15/790,100, filed on Oct. 23, 2017, granted, now 10,953,445.
Claims priority of provisional application 62/411,005, filed on Oct. 21, 2016.
Prior Publication US 2021/0354179 A1, Nov. 18, 2021
Int. Cl. B09B 3/70 (2022.01); A61L 31/02 (2006.01); A61L 31/04 (2006.01); A61L 31/14 (2006.01); G09F 3/00 (2006.01); B09B 3/00 (2022.01); B09B 101/65 (2022.01); C08K 3/26 (2006.01); C08K 3/34 (2006.01); C08L 33/02 (2006.01)
CPC B09B 3/70 (2022.01) [A61L 31/028 (2013.01); A61L 31/041 (2013.01); A61L 31/048 (2013.01); A61L 31/14 (2013.01); G09F 3/0291 (2013.01); B09B 2101/65 (2022.01); C08K 3/26 (2013.01); C08K 2003/265 (2013.01); C08K 3/34 (2013.01); C08K 3/346 (2013.01); C08L 33/02 (2013.01); C08L 2203/02 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A single procedure device indicator, comprising:
(a) a biocompatible composition comprising a superabsorbent polymer matrix, one or more binders, and one or more additives that are present in the biocompatible composition at predefined ratios by weight percentage in a mixture; and
(b) a surgical device at least partially enveloped by the biocompatible composition thereby forming at least one indicator region on the surgical device;
wherein the at least one indicator region is configured to elicit a volumetric and morphological modification in response to an exposure to water after a medical procedure; and
wherein the at least one indicator region is positioned on the surgical device to not come into contact with bodily fluids of a patient during the medical procedure.